Diseases & Disorders
(G50)
990 on File
AMERICAN MYALGIC ENCEPHALOMYELITIS & CHRONIC FATIGUE SYNDROME SOCIETY
Financial strength (30%)
47/100
Reliability (20%)
50/100
Effectiveness (25%)
31/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$57K
Total Revenue
$85K
Total Expenses
$38K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
2.8%
Fundraising Efficiency
N/A
Operating Reserve
5.36x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 903 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
2.8% | 79.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.4 mo | 21.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 99.4% |
P10P90
|
Bottom quarter |
|
Surplus margin
Surplus as a share of revenue
|
-50.8% | 13.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $57K | $85K | $38K | 2.8% | — |
| 2023 | $87K | $67K | $128K | 1.4% | — |
| 2022 | $39K | $31K | $108K | 5.0% | — |
| 2021 | $292K | $112K | N/A | — | 1 |
| 2020 | $71K | $27K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.